Advanced search
Publication Cover
Renal Failure Volume 46, 2024 - Issue 2
Submit an article Journal homepage
334
Views
0
CrossRef citations to date
0
Altmetric
Basic Sciences Investigations

Role of the gut microbiota in cefoperazone/sulbactam-induced epilepsy in mice with chronic renal failure

Yulu Wua Department of Nephrology, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, ChinaView further author information
,
Donghua Gub Department of Pathology, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, ChinaView further author information
,
Jie Lia Department of Nephrology, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, ChinaView further author information
,
Jing Lic Department of Neurology, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, ChinaCorrespondence[email protected]
View further author information
&
Guocun Houa Department of Nephrology, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1594-3645View further author information
ORCID Icon
Article: 2371551 | Received 16 Oct 2023, Accepted 18 Jun 2024, Published online: 28 Jun 2024

References

  • Wallace KL. Antibiotic-induced convulsions. Crit Care Clin. 1997;13(4):1–12. doi: 10.1016/s0749-0704(05)70367-5.
  • Tang QQ, Cao LH. Intestinal flora and neurological disorders. Chin J Biotechnol. 2021;37(11):3757–3780.
  • Ali BH, Al-Salam S, Al Za’abi M, et al. New model for adenine-induced chronic renal failure in mice, and the effect of gum acacia treatment thereon: comparison with rats. J Pharmacol Toxicol Methods. 2013;68(3):384–393. doi: 10.1016/j.vascn.2013.05.001.
  • Xu S, Rulian B, Xiu C. Pharmacological experimental methodology. Shanghai: People’s Health Publishing House; 2002.
  • Lei W, Mei D, Shuo LI. Cefoperazone sodium and sulbactam sodium (2:1). Chin J Clin Pharmacol. 2006;2006(9):932–935.
  • Chow KM, Szeto CC, Hui AC-F, et al. Retrospective review of neurotoxicity induced by cefepime and ceftazidime. Pharmacotherapy. 2003;23(3):369–373. doi: 10.1592/phco.23.3.369.32100.
  • Bilal M, Zoller M, Fuhr U, et al. Cefepime population pharmacokinetics, antibacterial target attainment, and estimated probability of neurotoxicity in critically ill patients. Antimicrob Agents Chemother. 2023;67(7):e0030923. doi: 10.1128/aac.00309-23.
  • Nguyen DD, Lai S. Prolonged cefepime-induced neurotoxicity in a patient with end-stage renal disease. Am J Case Rep. 2022;23:e934083. doi: 10.12659/AJCR.934083.
  • Chovatiya H, Shukla S, Desai S. Cefoperazone–sulbactam associated refractory seizures. Ann Indian Acad Neurol. 2021;24(5):784–786. doi: 10.4103/aian.AIAN_1278_20.
  • Meijers KIB, Evenepoel P. The gut–kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrol Dial Transplant. 2011;26(3):759–761. doi: 10.1093/ndt/gfq818.
  • Gao B, Jose A, Alonzo-Palma N, et al. Butyrate producing microbiota are reduced in chronic kidney diseases. Sci Rep. 2021;11(1):23530. doi: 10.1038/s41598-021-02865-0.
  • Vallianou NG, Kounatidis D, Panagopoulos F, et al. Gut microbiota and its role in the brain–gut–kidney axis in hypertension. Nat Rev Nephrol. 2018;14:442–456.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.